An anti-IL13Rα2 ADC was found to exert potent cytotoxic effects in IL13Rα2-positive diffuse intrinsic pontine glioma cell models and in vivo tumor models, with drug activity correlating strongly with IL13Rα2 expression levels (Lian et al., 2021). The gene discussed is IL13RA2; the disease is neoplasm.